Emergent BioSolutions
EBS
#7736
Rank
NZ$0.74 B
Marketcap
NZ$14.50
Share price
0.00%
Change (1 day)
25.78%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): NZ$0.28 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are NZ$0.75 Billion. In 2024 the company made an earning of -NZ$0.13 Billion, an increase over its 2023 earnings that were of -NZ$1.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.28 B-329.48%
2024 -NZ$0.13 Billion-88.82%
2023 -NZ$1.13 Billion242.73%
2022 -NZ$0.33 Billion-153.8%
2021 NZ$0.61 B-20.43%
2020 NZ$0.76 B278.02%
2019 NZ$0.20 B27.11%
2018 NZ$0.15 B-27.12%
2017 NZ$0.21 B17.21%
2016 NZ$0.18 B0.45%
2015 NZ$0.18 B73.51%
2014 NZ$0.10 B41.36%
2013 NZ$75.92 M35.2%
2012 NZ$56.15 M0.4%
2011 NZ$55.93 M-56.46%
2010 NZ$0.12 B76.73%
2009 NZ$72.68 M32.94%
2008 NZ$54.67 M-5.62%
2007 NZ$57.93 M
2005 NZ$83.87 M269.89%
2004 NZ$22.67 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.54 B 6,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$23.02 B 7,856.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.52 B 5,956.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$21.66 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.15 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.51 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.97 B 1,273.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel